nodes	percent_of_prediction	percent_of_DWPC	metapath
Vilazodone—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.16	0.216	CbGbCtD
Vilazodone—CYP3A4—Triamcinolone—ankylosing spondylitis	0.121	0.164	CbGbCtD
Vilazodone—CYP3A4—Betamethasone—ankylosing spondylitis	0.104	0.14	CbGbCtD
Vilazodone—CYP3A4—Prednisolone—ankylosing spondylitis	0.103	0.139	CbGbCtD
Vilazodone—CYP3A4—Prednisone—ankylosing spondylitis	0.0969	0.131	CbGbCtD
Vilazodone—CYP2D6—Dexamethasone—ankylosing spondylitis	0.0951	0.129	CbGbCtD
Vilazodone—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0605	0.0817	CbGbCtD
Vilazodone—Suicidal ideation—Methylprednisolone—ankylosing spondylitis	0.00576	0.0221	CcSEcCtD
Vilazodone—Mania—Methylprednisolone—ankylosing spondylitis	0.00555	0.0213	CcSEcCtD
Vilazodone—Suicidal ideation—Betamethasone—ankylosing spondylitis	0.00524	0.0201	CcSEcCtD
Vilazodone—Suicidal ideation—Dexamethasone—ankylosing spondylitis	0.00524	0.0201	CcSEcCtD
Vilazodone—Mania—Betamethasone—ankylosing spondylitis	0.00505	0.0194	CcSEcCtD
Vilazodone—Mania—Dexamethasone—ankylosing spondylitis	0.00505	0.0194	CcSEcCtD
Vilazodone—Suicidal ideation—Prednisone—ankylosing spondylitis	0.00456	0.0175	CcSEcCtD
Vilazodone—Mania—Prednisone—ankylosing spondylitis	0.0044	0.0169	CcSEcCtD
Vilazodone—Cataract—Triamcinolone—ankylosing spondylitis	0.00425	0.0163	CcSEcCtD
Vilazodone—Cataract—Dexamethasone—ankylosing spondylitis	0.00386	0.0148	CcSEcCtD
Vilazodone—Cataract—Betamethasone—ankylosing spondylitis	0.00386	0.0148	CcSEcCtD
Vilazodone—Increased appetite—Prednisolone—ankylosing spondylitis	0.0034	0.0131	CcSEcCtD
Vilazodone—Dry eye—Dexamethasone—ankylosing spondylitis	0.00339	0.013	CcSEcCtD
Vilazodone—Dry eye—Betamethasone—ankylosing spondylitis	0.00339	0.013	CcSEcCtD
Vilazodone—Cataract—Prednisone—ankylosing spondylitis	0.00336	0.0129	CcSEcCtD
Vilazodone—Increased appetite—Triamcinolone—ankylosing spondylitis	0.00313	0.012	CcSEcCtD
Vilazodone—Increased appetite—Methylprednisolone—ankylosing spondylitis	0.00312	0.012	CcSEcCtD
Vilazodone—Increased appetite—Dexamethasone—ankylosing spondylitis	0.00284	0.0109	CcSEcCtD
Vilazodone—Increased appetite—Betamethasone—ankylosing spondylitis	0.00284	0.0109	CcSEcCtD
Vilazodone—Irritability—Methylprednisolone—ankylosing spondylitis	0.0028	0.0108	CcSEcCtD
Vilazodone—Breast disorder—Methylprednisolone—ankylosing spondylitis	0.00265	0.0102	CcSEcCtD
Vilazodone—Migraine—Dexamethasone—ankylosing spondylitis	0.00262	0.0101	CcSEcCtD
Vilazodone—Migraine—Betamethasone—ankylosing spondylitis	0.00262	0.0101	CcSEcCtD
Vilazodone—Irritability—Betamethasone—ankylosing spondylitis	0.00254	0.00978	CcSEcCtD
Vilazodone—Irritability—Dexamethasone—ankylosing spondylitis	0.00254	0.00978	CcSEcCtD
Vilazodone—Increased appetite—Prednisone—ankylosing spondylitis	0.00247	0.0095	CcSEcCtD
Vilazodone—Irritability—Prednisone—ankylosing spondylitis	0.00222	0.00852	CcSEcCtD
Vilazodone—Hallucination—Methylprednisolone—ankylosing spondylitis	0.00202	0.00776	CcSEcCtD
Vilazodone—Connective tissue disorder—Methylprednisolone—ankylosing spondylitis	0.00199	0.00766	CcSEcCtD
Vilazodone—Eye disorder—Methylprednisolone—ankylosing spondylitis	0.00189	0.00729	CcSEcCtD
Vilazodone—Cardiac disorder—Methylprednisolone—ankylosing spondylitis	0.00188	0.00724	CcSEcCtD
Vilazodone—Irritability—Methotrexate—ankylosing spondylitis	0.00185	0.00712	CcSEcCtD
Vilazodone—Erectile dysfunction—Prednisone—ankylosing spondylitis	0.00185	0.0071	CcSEcCtD
Vilazodone—Hallucination—Dexamethasone—ankylosing spondylitis	0.00183	0.00705	CcSEcCtD
Vilazodone—Hallucination—Betamethasone—ankylosing spondylitis	0.00183	0.00705	CcSEcCtD
Vilazodone—Vision blurred—Prednisolone—ankylosing spondylitis	0.00181	0.00697	CcSEcCtD
Vilazodone—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.00178	0.00683	CcSEcCtD
Vilazodone—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.00176	0.00679	CcSEcCtD
Vilazodone—Breast disorder—Methotrexate—ankylosing spondylitis	0.00175	0.00674	CcSEcCtD
Vilazodone—Dysgeusia—Triamcinolone—ankylosing spondylitis	0.00173	0.00666	CcSEcCtD
Vilazodone—Eye disorder—Betamethasone—ankylosing spondylitis	0.00172	0.00663	CcSEcCtD
Vilazodone—Eye disorder—Dexamethasone—ankylosing spondylitis	0.00172	0.00663	CcSEcCtD
Vilazodone—Convulsion—Prednisolone—ankylosing spondylitis	0.00167	0.00641	CcSEcCtD
Vilazodone—Hallucination—Prednisone—ankylosing spondylitis	0.0016	0.00614	CcSEcCtD
Vilazodone—Connective tissue disorder—Prednisone—ankylosing spondylitis	0.00158	0.00607	CcSEcCtD
Vilazodone—Erectile dysfunction—Methotrexate—ankylosing spondylitis	0.00154	0.00594	CcSEcCtD
Vilazodone—Convulsion—Triamcinolone—ankylosing spondylitis	0.00153	0.00589	CcSEcCtD
Vilazodone—Convulsion—Methylprednisolone—ankylosing spondylitis	0.00153	0.00588	CcSEcCtD
Vilazodone—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.00152	0.00584	CcSEcCtD
Vilazodone—Arthralgia—Methylprednisolone—ankylosing spondylitis	0.0015	0.00578	CcSEcCtD
Vilazodone—Eye disorder—Prednisone—ankylosing spondylitis	0.0015	0.00577	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00149	0.00574	CcSEcCtD
Vilazodone—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00147	0.00566	CcSEcCtD
Vilazodone—Insomnia—Prednisolone—ankylosing spondylitis	0.00142	0.00546	CcSEcCtD
Vilazodone—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00141	0.00543	CcSEcCtD
Vilazodone—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00141	0.00542	CcSEcCtD
Vilazodone—Mental disorder—Prednisone—ankylosing spondylitis	0.00141	0.00541	CcSEcCtD
Vilazodone—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.0014	0.00538	CcSEcCtD
Vilazodone—Malnutrition—Prednisone—ankylosing spondylitis	0.0014	0.00538	CcSEcCtD
Vilazodone—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.0014	0.00537	CcSEcCtD
Vilazodone—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00139	0.00535	CcSEcCtD
Vilazodone—Convulsion—Dexamethasone—ankylosing spondylitis	0.00139	0.00535	CcSEcCtD
Vilazodone—Convulsion—Betamethasone—ankylosing spondylitis	0.00139	0.00535	CcSEcCtD
Vilazodone—Vision blurred—Prednisone—ankylosing spondylitis	0.00132	0.00507	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Triamcinolone—ankylosing spondylitis	0.00132	0.00506	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Methylprednisolone—ankylosing spondylitis	0.00131	0.00505	CcSEcCtD
Vilazodone—Insomnia—Triamcinolone—ankylosing spondylitis	0.00131	0.00502	CcSEcCtD
Vilazodone—Insomnia—Methylprednisolone—ankylosing spondylitis	0.0013	0.00501	CcSEcCtD
Vilazodone—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.0013	0.00499	CcSEcCtD
Vilazodone—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00129	0.00497	CcSEcCtD
Vilazodone—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00129	0.00497	CcSEcCtD
Vilazodone—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00128	0.00494	CcSEcCtD
Vilazodone—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00128	0.00494	CcSEcCtD
Vilazodone—Agitation—Prednisone—ankylosing spondylitis	0.00128	0.00494	CcSEcCtD
Vilazodone—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00127	0.00489	CcSEcCtD
Vilazodone—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00127	0.00488	CcSEcCtD
Vilazodone—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.00127	0.00487	CcSEcCtD
Vilazodone—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.00127	0.00487	CcSEcCtD
Vilazodone—Eye disorder—Methotrexate—ankylosing spondylitis	0.00125	0.00482	CcSEcCtD
Vilazodone—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.00125	0.00479	CcSEcCtD
Vilazodone—Fatigue—Triamcinolone—ankylosing spondylitis	0.00124	0.00479	CcSEcCtD
Vilazodone—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00124	0.00478	CcSEcCtD
Vilazodone—Convulsion—Prednisone—ankylosing spondylitis	0.00121	0.00466	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Betamethasone—ankylosing spondylitis	0.00119	0.00459	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Dexamethasone—ankylosing spondylitis	0.00119	0.00459	CcSEcCtD
Vilazodone—Arthralgia—Prednisone—ankylosing spondylitis	0.00119	0.00458	CcSEcCtD
Vilazodone—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.00119	0.00457	CcSEcCtD
Vilazodone—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.00119	0.00456	CcSEcCtD
Vilazodone—Insomnia—Betamethasone—ankylosing spondylitis	0.00118	0.00456	CcSEcCtD
Vilazodone—Insomnia—Dexamethasone—ankylosing spondylitis	0.00118	0.00456	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.00118	0.00454	CcSEcCtD
Vilazodone—Paraesthesia—Betamethasone—ankylosing spondylitis	0.00118	0.00452	CcSEcCtD
Vilazodone—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.00118	0.00452	CcSEcCtD
Vilazodone—Mental disorder—Methotrexate—ankylosing spondylitis	0.00118	0.00452	CcSEcCtD
Vilazodone—Malnutrition—Methotrexate—ankylosing spondylitis	0.00117	0.00449	CcSEcCtD
Vilazodone—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00115	0.00443	CcSEcCtD
Vilazodone—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00115	0.00443	CcSEcCtD
Vilazodone—Dysgeusia—Methotrexate—ankylosing spondylitis	0.00114	0.0044	CcSEcCtD
Vilazodone—Decreased appetite—Betamethasone—ankylosing spondylitis	0.00114	0.00438	CcSEcCtD
Vilazodone—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.00114	0.00438	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00113	0.00435	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00113	0.00435	CcSEcCtD
Vilazodone—Fatigue—Dexamethasone—ankylosing spondylitis	0.00113	0.00434	CcSEcCtD
Vilazodone—Fatigue—Betamethasone—ankylosing spondylitis	0.00113	0.00434	CcSEcCtD
Vilazodone—Nervous system disorder—Prednisone—ankylosing spondylitis	0.00112	0.0043	CcSEcCtD
Vilazodone—Skin disorder—Prednisone—ankylosing spondylitis	0.00111	0.00426	CcSEcCtD
Vilazodone—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.0011	0.00424	CcSEcCtD
Vilazodone—Vision blurred—Methotrexate—ankylosing spondylitis	0.0011	0.00423	CcSEcCtD
Vilazodone—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.00108	0.00415	CcSEcCtD
Vilazodone—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.00108	0.00415	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Prednisone—ankylosing spondylitis	0.00104	0.004	CcSEcCtD
Vilazodone—Dizziness—Prednisolone—ankylosing spondylitis	0.00104	0.00399	CcSEcCtD
Vilazodone—Asthenia—Triamcinolone—ankylosing spondylitis	0.00104	0.00398	CcSEcCtD
Vilazodone—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00103	0.00397	CcSEcCtD
Vilazodone—Insomnia—Prednisone—ankylosing spondylitis	0.00103	0.00397	CcSEcCtD
Vilazodone—Paraesthesia—Prednisone—ankylosing spondylitis	0.00102	0.00394	CcSEcCtD
Vilazodone—Convulsion—Methotrexate—ankylosing spondylitis	0.00101	0.00389	CcSEcCtD
Vilazodone—Dyspepsia—Prednisone—ankylosing spondylitis	0.001	0.00386	CcSEcCtD
Vilazodone—Arthralgia—Methotrexate—ankylosing spondylitis	0.000994	0.00382	CcSEcCtD
Vilazodone—Decreased appetite—Prednisone—ankylosing spondylitis	0.000992	0.00381	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000988	0.0038	CcSEcCtD
Vilazodone—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000986	0.00379	CcSEcCtD
Vilazodone—Fatigue—Prednisone—ankylosing spondylitis	0.000983	0.00378	CcSEcCtD
Vilazodone—Dizziness—Triamcinolone—ankylosing spondylitis	0.000955	0.00367	CcSEcCtD
Vilazodone—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000953	0.00366	CcSEcCtD
Vilazodone—Feeling abnormal—Prednisone—ankylosing spondylitis	0.00094	0.00361	CcSEcCtD
Vilazodone—Asthenia—Betamethasone—ankylosing spondylitis	0.00094	0.00361	CcSEcCtD
Vilazodone—Asthenia—Dexamethasone—ankylosing spondylitis	0.00094	0.00361	CcSEcCtD
Vilazodone—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000935	0.0036	CcSEcCtD
Vilazodone—Nausea—Prednisolone—ankylosing spondylitis	0.000932	0.00359	CcSEcCtD
Vilazodone—Skin disorder—Methotrexate—ankylosing spondylitis	0.000926	0.00356	CcSEcCtD
Vilazodone—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000922	0.00354	CcSEcCtD
Vilazodone—Vomiting—Triamcinolone—ankylosing spondylitis	0.000918	0.00353	CcSEcCtD
Vilazodone—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000916	0.00352	CcSEcCtD
Vilazodone—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000896	0.00345	CcSEcCtD
Vilazodone—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000896	0.00345	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Methotrexate—ankylosing spondylitis	0.000869	0.00334	CcSEcCtD
Vilazodone—Dizziness—Betamethasone—ankylosing spondylitis	0.000866	0.00333	CcSEcCtD
Vilazodone—Dizziness—Dexamethasone—ankylosing spondylitis	0.000866	0.00333	CcSEcCtD
Vilazodone—Insomnia—Methotrexate—ankylosing spondylitis	0.000862	0.00332	CcSEcCtD
Vilazodone—Nausea—Triamcinolone—ankylosing spondylitis	0.000857	0.0033	CcSEcCtD
Vilazodone—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000856	0.00329	CcSEcCtD
Vilazodone—Nausea—Methylprednisolone—ankylosing spondylitis	0.000856	0.00329	CcSEcCtD
Vilazodone—Somnolence—Methotrexate—ankylosing spondylitis	0.000848	0.00326	CcSEcCtD
Vilazodone—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000839	0.00323	CcSEcCtD
Vilazodone—Vomiting—Dexamethasone—ankylosing spondylitis	0.000833	0.0032	CcSEcCtD
Vilazodone—Vomiting—Betamethasone—ankylosing spondylitis	0.000833	0.0032	CcSEcCtD
Vilazodone—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000829	0.00319	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000823	0.00317	CcSEcCtD
Vilazodone—Fatigue—Methotrexate—ankylosing spondylitis	0.000822	0.00316	CcSEcCtD
Vilazodone—Asthenia—Prednisone—ankylosing spondylitis	0.000818	0.00315	CcSEcCtD
Vilazodone—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000786	0.00302	CcSEcCtD
Vilazodone—Diarrhoea—Prednisone—ankylosing spondylitis	0.00078	0.003	CcSEcCtD
Vilazodone—Nausea—Betamethasone—ankylosing spondylitis	0.000778	0.00299	CcSEcCtD
Vilazodone—Nausea—Dexamethasone—ankylosing spondylitis	0.000778	0.00299	CcSEcCtD
Vilazodone—Dizziness—Prednisone—ankylosing spondylitis	0.000754	0.0029	CcSEcCtD
Vilazodone—Vomiting—Prednisone—ankylosing spondylitis	0.000725	0.00279	CcSEcCtD
Vilazodone—Asthenia—Methotrexate—ankylosing spondylitis	0.000684	0.00263	CcSEcCtD
Vilazodone—Nausea—Prednisone—ankylosing spondylitis	0.000678	0.00261	CcSEcCtD
Vilazodone—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000652	0.00251	CcSEcCtD
Vilazodone—Dizziness—Methotrexate—ankylosing spondylitis	0.00063	0.00242	CcSEcCtD
Vilazodone—Vomiting—Methotrexate—ankylosing spondylitis	0.000606	0.00233	CcSEcCtD
Vilazodone—Nausea—Methotrexate—ankylosing spondylitis	0.000566	0.00218	CcSEcCtD
